Dardi F, Boucly A, Benza R, Frantz R, Mercurio V, Olschewski H
Eur Respir J. 2024; 64(4).
PMID: 39209472
PMC: 11525341.
DOI: 10.1183/13993003.01323-2024.
Lokhorst C, van der Werf S, Berger R, Douwes J
J Am Heart Assoc. 2024; 13(13):e034151.
PMID: 38904230
PMC: 11255703.
DOI: 10.1161/JAHA.123.034151.
Khan S, Mathai S
Curr Opin Pulm Med. 2023; 29(5):380-390.
PMID: 37461869
PMC: 11334969.
DOI: 10.1097/MCP.0000000000001001.
Chen X, Quan R, Qian Y, Yang Z, Yu Z, Zhang C
Rheumatology (Oxford). 2023; 62(11):3555-3564.
PMID: 36912696
PMC: 10629783.
DOI: 10.1093/rheumatology/kead103.
Huang W, Hsieh S, Wu Y, Hsieh T, Wu Y, Li K
Acta Cardiol Sin. 2023; 39(2):213-241.
PMID: 36911549
PMC: 9999177.
DOI: 10.6515/ACS.202303_39(2).20230117A.
The diagnostic and prognostic value of growth differentiation factor-15 in systemic lupus erythematosus-associated pulmonary arterial hypertension.
Qian J, Ding Y, Yang X, Wang Q, Zhao J, Liu Y
Pulm Circ. 2023; 13(1):e12195.
PMID: 36788942
PMC: 9912020.
DOI: 10.1002/pul2.12195.
2020 Chinese Expert-based Consensus on the Diagnosis and Treatment of Connective Tissue Disease Associated Pulmonary Arterial Hypertension.
Zhao J, Wang Q, Wang Q, Zhang Y, Zhang N, Zhang R
Rheumatol Immunol Res. 2022; 2(2):63-78.
PMID: 36465975
PMC: 9524783.
DOI: 10.2478/rir-2021-0010.
Risk stratification in adult and pediatric pulmonary arterial hypertension: A systematic review.
Lokhorst C, van der Werf S, Berger R, Douwes J
Front Cardiovasc Med. 2022; 9:1035453.
PMID: 36440049
PMC: 9684185.
DOI: 10.3389/fcvm.2022.1035453.
Improved Survival for Patients with Systemic Sclerosis-associated Pulmonary Arterial Hypertension: The Johns Hopkins Registry.
Hassan H, Naranjo M, Ayoub N, Housten T, Hsu S, Balasubramanian A
Am J Respir Crit Care Med. 2022; 207(3):312-322.
PMID: 36173815
PMC: 9896646.
DOI: 10.1164/rccm.202204-0731OC.
Risk assessment in systemic lupus erythematosus-associated pulmonary arterial hypertension: CSTAR-PAH cohort study.
Wang Q, Qian J, Li M, Zhang X, Wei W, Zuo X
Ther Adv Chronic Dis. 2022; 13:20406223221112528.
PMID: 35898921
PMC: 9310292.
DOI: 10.1177/20406223221112528.
Cross-cultural validation of the Chinese version of the EmPHasis-10 questionnaire in connective tissue disease patients with pulmonary arterial hypertension and its relationship with risk stratification.
Shi Y, Dong X, Hu X, Weng L, Liu Y, Lai J
BMC Pulm Med. 2022; 22(1):264.
PMID: 35790938
PMC: 9258076.
DOI: 10.1186/s12890-022-02056-1.
Regular Risk Assessment in Pulmonary Arterial Hypertension - A Whistleblower for Hidden Disease Progression.
Wu S, Wu Y
Acta Cardiol Sin. 2022; 38(2):113-123.
PMID: 35273432
PMC: 8888324.
DOI: 10.6515/ACS.202203_38(2).20211005A.
Early risk prediction in idiopathic connective tissue disease-associated pulmonary arterial hypertension: call for a refined assessment.
Hjalmarsson C, Kjellstrom B, Jansson K, Nisell M, Kylhammar D, Kavianipour M
ERJ Open Res. 2021; 7(3).
PMID: 34350280
PMC: 8326683.
DOI: 10.1183/23120541.00854-2020.
A novel approach to perioperative risk assessment for patients with pulmonary hypertension.
Hassan H, Housten T, Balasubramanian A, Simpson C, Damico R, Mathai S
ERJ Open Res. 2021; 7(3).
PMID: 34291108
PMC: 8287131.
DOI: 10.1183/23120541.00257-2021.
Pulmonary Hypertension Phenotypes in Systemic Sclerosis: The Right Diagnosis for the Right Treatment.
Attanasio U, Cuomo A, Pirozzi F, Loffredo S, Abete P, Petretta M
Int J Mol Sci. 2020; 21(12).
PMID: 32580360
PMC: 7352262.
DOI: 10.3390/ijms21124430.
The role of pulmonary arterial hypertension-targeted therapy in systemic sclerosis.
Lee M, Bull T
F1000Res. 2020; 8.
PMID: 32025283
PMC: 6971837.
DOI: 10.12688/f1000research.20313.1.
Cardiac Catheterization versus Echocardiography for Monitoring Pulmonary Pressure: A Prospective Study in Patients with Connective Tissue Disease-Associated Pulmonary Arterial Hypertension.
Bournia V, Tsangaris I, Rallidis L, Konstantonis D, Frantzeskaki F, Anthi A
Diagnostics (Basel). 2020; 10(1).
PMID: 31963800
PMC: 7168199.
DOI: 10.3390/diagnostics10010049.
Learning from registries in pulmonary arterial hypertension: pitfalls and recommendations.
Swinnen K, Quarck R, Godinas L, Belge C, Delcroix M
Eur Respir Rev. 2019; 28(154).
PMID: 31852746
PMC: 9488628.
DOI: 10.1183/16000617.0050-2019.
Progress in Understanding, Diagnosing, and Managing Cardiac Complications of Systemic Sclerosis.
Hung G, Mercurio V, Hsu S, Mathai S, Shah A, Mukherjee M
Curr Rheumatol Rep. 2019; 21(12):68.
PMID: 31813082
PMC: 11151284.
DOI: 10.1007/s11926-019-0867-0.
Selexipag in the management of pulmonary arterial hypertension: an update.
Coghlan J, Picken C, Clapp L
Drug Healthc Patient Saf. 2019; 11:55-64.
PMID: 31496830
PMC: 6689562.
DOI: 10.2147/DHPS.S181313.
